![Oliver Baumann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 8 M $ al 31/08/2026
Oliver R.
Baumann is Chief Executive Officer & Director at Xlife Sciences AG since 2020, Chief Executive Officer at Akira Trading GmbH, Chairman at Akira Holding AG, Chairman & General Manager at Veraxa Biotech Holding AG, Director at Pecunia Solutions AG, Director at VERAXA Biotech AG, Director at Axenoll Life Sciences AG, and Co-Managing Director at Xrna.
Biotech GmbH.
Former roles include Chief Executive Officer at Belvoir Wealth Management AG and Co-Managing Director at x-diagnostics GmbH.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
4,08 % | 27/08/2026 | 5.773.618 ( 4,08 % ) | 8 M $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| XLIFE SCIENCES AG | Director Ejecutivo | 01/07/2019 |
Pecunia Solutions AG | Director/Miembro de la Junta | - |
Axenoll Life Sciences AG | Director/Miembro de la Junta | - |
Akira Holding AG | Presidente | - |
| Empresas | Cargo | Fin |
|---|---|---|
Veraxa Biotech AG
 Veraxa Biotech AG BiotechnologyHealth Technology Develops antibodies based therapeutics | Director/Miembro de la Junta | - |
Belvoir Wealth Management AG
 Belvoir Wealth Management AG Investment ManagersFinance Provides investment advice | Director Ejecutivo | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 6 |
|---|---|
Belvoir Wealth Management AG
Belvoir Wealth Management AG Investment ManagersFinance Provides investment advice | Finance |
Pecunia Solutions AG | |
Xlife Sciences AG
 Xlife Sciences AG Miscellaneous Commercial ServicesCommercial Services Develops life sciences technologies | Commercial Services |
Akira Holding AG | |
Veraxa Biotech AG
Veraxa Biotech AG BiotechnologyHealth Technology Develops antibodies based therapeutics | Health Technology |
Axenoll Life Sciences AG |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
